Log In
Monday 19th March 2018

NICE in court challenge over osteoporosis treatment

19th January 2009

The National Institute for Health and Clinical Excellence (NICE) is facing a High Court legal challenge in respect to its ruling on an osteoporosis treatment.

NICE guidance tells doctors to prescribe the least costly medication available to women who have early signs of the disease, although one in five cannot take the drug because of its severe side effects. The National Osteoporosis Society and the drug manufacturer Servier have argued that the decision is "unethical" and will contest it at the High Court.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018